Venable Leads Dechra's £221M Veterinary Drugmaker Addition
Dechra Pharmaceuticals PLC said on Tuesday that it has bought a California-based manufacturer of veterinary medicines for £221.5 million ($260 million), in a deal guided by Venable LLP, as the British business...To view the full article, register now.
Already a subscriber? Click here to view full article